Shares of Genus plc (LON:GNS - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,775.30 ($23.89) and traded as high as GBX 2,065 ($27.79). Genus shares last traded at GBX 2,060 ($27.73), with a volume of 42,084 shares trading hands.
Analyst Ratings Changes
Separately, Shore Capital restated a "buy" rating on shares of Genus in a research report on Wednesday, April 30th.
Read Our Latest Research Report on Genus
Genus Price Performance
The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The firm has a market cap of £1.32 billion, a P/E ratio of 167.03, a PEG ratio of 2.87 and a beta of 0.37. The firm has a 50-day simple moving average of GBX 1,858.94 and a 200-day simple moving average of GBX 1,779.18.
Genus (LON:GNS - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported GBX 39.80 ($0.54) earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. As a group, analysts forecast that Genus plc will post 70.9644323 EPS for the current year.
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Articles
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
